Peter G. Traber

Who is Peter G. Traber?

Peter George Traber currently serves as President and Chief Executive Officer for Galectin Therapeutics.

He formerly was the president and chief executive officer of Baylor College of Medicine and the John and Clara Whitmore Professor of Medicine. Traber succeeded Ralph Feigin to become the fourth president of BCM in March 2003, and was president until November 2008. Prior to joining Baylor, he served as Senior Vice President for Clinical Development & Medical Affairs and Chief Medical Officer at GlaxoSmithKline. Prior to that, Traber held positions as Chief Executive Officer of the University of Pennsylvania Health System and interim Dean, Chair of the Department of Internal Medicine for the University of Pennsylvania School of Medicine, Chief of Gastroenterology at the University of Pennsylvania School of Medicine, and faculty member at the University of Michigan School of Medicine.